Pilot open-label RCT, 53 adults with chronic central serous chorioretinopathy: subretinal fluid fully resolved in 90% on topical difluprednate vs 45% on oral eplerenone and 23% with observation (P<0.001); 30% of difluprednate eyes had ocular hypertension.
RCTn = 53
Yadav et al. EVALUATING THE EFFICACY AND SAFETY OF TOPICAL DIFLUPREDNATE IN PATIENTS WITH CHRONIC CENTRAL SEROUS CHORIORETINOPATHY